nodes	percent_of_prediction	percent_of_DWPC	metapath
Papaverine—PDE3B—brown adipose tissue—type 2 diabetes mellitus	0.0603	0.312	CbGeAlD
Papaverine—PDE3A—penis—type 2 diabetes mellitus	0.035	0.181	CbGeAlD
Papaverine—PDE3B—islet of Langerhans—type 2 diabetes mellitus	0.0128	0.0659	CbGeAlD
Papaverine—PDE10A—nephron tubule—type 2 diabetes mellitus	0.011	0.057	CbGeAlD
Papaverine—PDE3B—cardiovascular system—type 2 diabetes mellitus	0.00923	0.0477	CbGeAlD
Papaverine—PDE3B—pancreas—type 2 diabetes mellitus	0.00897	0.0463	CbGeAlD
Papaverine—PDE10A—adipose tissue—type 2 diabetes mellitus	0.00873	0.0451	CbGeAlD
Papaverine—PDE3B—adipose tissue—type 2 diabetes mellitus	0.00814	0.042	CbGeAlD
Papaverine—PDE3B—liver—type 2 diabetes mellitus	0.00571	0.0295	CbGeAlD
Papaverine—PDE3A—cardiovascular system—type 2 diabetes mellitus	0.00564	0.0291	CbGeAlD
Papaverine—PDE4B—islet of Langerhans—type 2 diabetes mellitus	0.00562	0.029	CbGeAlD
Papaverine—Hepatitis—Acarbose—type 2 diabetes mellitus	0.00507	0.0123	CcSEcCtD
Papaverine—PDE3A—adipose tissue—type 2 diabetes mellitus	0.00497	0.0257	CbGeAlD
Papaverine—Blood pressure increased—Gliclazide—type 2 diabetes mellitus	0.00482	0.0117	CcSEcCtD
Papaverine—Blood pressure increased—Valsartan—type 2 diabetes mellitus	0.00442	0.0107	CcSEcCtD
Papaverine—Ill-defined disorder—Tolazamide—type 2 diabetes mellitus	0.00426	0.0103	CcSEcCtD
Papaverine—Hepatitis—Repaglinide—type 2 diabetes mellitus	0.00423	0.0103	CcSEcCtD
Papaverine—Abdominal discomfort—Glipizide—type 2 diabetes mellitus	0.00419	0.0102	CcSEcCtD
Papaverine—Malaise—Tolazamide—type 2 diabetes mellitus	0.00414	0.0101	CcSEcCtD
Papaverine—Vertigo—Tolazamide—type 2 diabetes mellitus	0.00413	0.01	CcSEcCtD
Papaverine—Hepatitis—Rosiglitazone—type 2 diabetes mellitus	0.004	0.0097	CcSEcCtD
Papaverine—PDE4B—pancreas—type 2 diabetes mellitus	0.00395	0.0204	CbGeAlD
Papaverine—Constipation—Miglitol—type 2 diabetes mellitus	0.00392	0.00951	CcSEcCtD
Papaverine—Abdominal discomfort—Sitagliptin—type 2 diabetes mellitus	0.0039	0.00946	CcSEcCtD
Papaverine—PDE4B—cortex of kidney—type 2 diabetes mellitus	0.00387	0.02	CbGeAlD
Papaverine—Discomfort—Tolazamide—type 2 diabetes mellitus	0.00386	0.00938	CcSEcCtD
Papaverine—Blood pressure increased—Irbesartan—type 2 diabetes mellitus	0.0038	0.00923	CcSEcCtD
Papaverine—PDE4B—adipose tissue—type 2 diabetes mellitus	0.00358	0.0185	CbGeAlD
Papaverine—Anorexia—Chlorpropamide—type 2 diabetes mellitus	0.00357	0.00867	CcSEcCtD
Papaverine—Abdominal discomfort—Bromocriptine—type 2 diabetes mellitus	0.00353	0.00857	CcSEcCtD
Papaverine—Hepatitis—Glipizide—type 2 diabetes mellitus	0.0035	0.00849	CcSEcCtD
Papaverine—PDE3A—liver—type 2 diabetes mellitus	0.00349	0.018	CbGeAlD
Papaverine—Hepatitis—Pioglitazone—type 2 diabetes mellitus	0.00335	0.00814	CcSEcCtD
Papaverine—Hepatitis—Glimepiride—type 2 diabetes mellitus	0.00327	0.00793	CcSEcCtD
Papaverine—Decreased appetite—Chlorpropamide—type 2 diabetes mellitus	0.00326	0.00791	CcSEcCtD
Papaverine—Flushing—Glipizide—type 2 diabetes mellitus	0.00325	0.00788	CcSEcCtD
Papaverine—Verapamil—KCNJ11—type 2 diabetes mellitus	0.00321	0.299	CrCbGaD
Papaverine—Constipation—Linagliptin—type 2 diabetes mellitus	0.00317	0.0077	CcSEcCtD
Papaverine—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.00313	0.00761	CcSEcCtD
Papaverine—Feeling abnormal—Tolazamide—type 2 diabetes mellitus	0.00309	0.0075	CcSEcCtD
Papaverine—Constipation—Acarbose—type 2 diabetes mellitus	0.00308	0.00747	CcSEcCtD
Papaverine—Abdominal discomfort—Gliclazide—type 2 diabetes mellitus	0.0029	0.00703	CcSEcCtD
Papaverine—Rash—Miglitol—type 2 diabetes mellitus	0.00289	0.00701	CcSEcCtD
Papaverine—Dermatitis—Miglitol—type 2 diabetes mellitus	0.00289	0.00701	CcSEcCtD
Papaverine—Ill-defined disorder—Glipizide—type 2 diabetes mellitus	0.00283	0.00686	CcSEcCtD
Papaverine—Malaise—Glipizide—type 2 diabetes mellitus	0.00275	0.00667	CcSEcCtD
Papaverine—Vertigo—Glipizide—type 2 diabetes mellitus	0.00274	0.00664	CcSEcCtD
Papaverine—Nausea—Miglitol—type 2 diabetes mellitus	0.00272	0.00661	CcSEcCtD
Papaverine—Ill-defined disorder—Pioglitazone—type 2 diabetes mellitus	0.00271	0.00657	CcSEcCtD
Papaverine—Hepatitis—Glyburide—type 2 diabetes mellitus	0.00269	0.00654	CcSEcCtD
Papaverine—Malaise—Pioglitazone—type 2 diabetes mellitus	0.00263	0.00639	CcSEcCtD
Papaverine—Abdominal discomfort—Orlistat—type 2 diabetes mellitus	0.00263	0.00638	CcSEcCtD
Papaverine—Ill-defined disorder—Sitagliptin—type 2 diabetes mellitus	0.00263	0.00638	CcSEcCtD
Papaverine—Vertigo—Pioglitazone—type 2 diabetes mellitus	0.00262	0.00636	CcSEcCtD
Papaverine—Rash—Tolbutamide—type 2 diabetes mellitus	0.0026	0.0063	CcSEcCtD
Papaverine—Headache—Tolbutamide—type 2 diabetes mellitus	0.00258	0.00626	CcSEcCtD
Papaverine—Constipation—Repaglinide—type 2 diabetes mellitus	0.00257	0.00624	CcSEcCtD
Papaverine—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.00256	0.00622	CcSEcCtD
Papaverine—Discomfort—Glipizide—type 2 diabetes mellitus	0.00256	0.00622	CcSEcCtD
Papaverine—Malaise—Sitagliptin—type 2 diabetes mellitus	0.00256	0.0062	CcSEcCtD
Papaverine—Vertigo—Sitagliptin—type 2 diabetes mellitus	0.00255	0.00618	CcSEcCtD
Papaverine—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.00254	0.00616	CcSEcCtD
Papaverine—PDE4B—liver—type 2 diabetes mellitus	0.00251	0.013	CbGeAlD
Papaverine—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.00246	0.00598	CcSEcCtD
Papaverine—Discomfort—Pioglitazone—type 2 diabetes mellitus	0.00245	0.00596	CcSEcCtD
Papaverine—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00245	0.00594	CcSEcCtD
Papaverine—Constipation—Rosiglitazone—type 2 diabetes mellitus	0.00243	0.0059	CcSEcCtD
Papaverine—Abdominal discomfort—Metformin—type 2 diabetes mellitus	0.00242	0.00588	CcSEcCtD
Papaverine—Hepatitis—Gliclazide—type 2 diabetes mellitus	0.00242	0.00587	CcSEcCtD
Papaverine—Discomfort—Sitagliptin—type 2 diabetes mellitus	0.00238	0.00579	CcSEcCtD
Papaverine—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00238	0.00577	CcSEcCtD
Papaverine—Anorexia—Glipizide—type 2 diabetes mellitus	0.00237	0.00575	CcSEcCtD
Papaverine—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00236	0.00574	CcSEcCtD
Papaverine—Rash—Tolazamide—type 2 diabetes mellitus	0.00236	0.00574	CcSEcCtD
Papaverine—Headache—Tolazamide—type 2 diabetes mellitus	0.00235	0.0057	CcSEcCtD
Papaverine—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00235	0.0057	CcSEcCtD
Papaverine—Rash—Linagliptin—type 2 diabetes mellitus	0.00234	0.00568	CcSEcCtD
Papaverine—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00234	0.00567	CcSEcCtD
Papaverine—Headache—Linagliptin—type 2 diabetes mellitus	0.00232	0.00564	CcSEcCtD
Papaverine—Vertigo—Bromocriptine—type 2 diabetes mellitus	0.0023	0.00559	CcSEcCtD
Papaverine—Rash—Acarbose—type 2 diabetes mellitus	0.00227	0.00551	CcSEcCtD
Papaverine—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00227	0.00551	CcSEcCtD
Papaverine—Flushing—Gliclazide—type 2 diabetes mellitus	0.00224	0.00545	CcSEcCtD
Papaverine—Nausea—Tolazamide—type 2 diabetes mellitus	0.00223	0.0054	CcSEcCtD
Papaverine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00223	0.0054	CcSEcCtD
Papaverine—Hepatitis—Valsartan—type 2 diabetes mellitus	0.00222	0.00539	CcSEcCtD
Papaverine—Anorexia—Glimepiride—type 2 diabetes mellitus	0.00221	0.00537	CcSEcCtD
Papaverine—Hepatitis—Orlistat—type 2 diabetes mellitus	0.0022	0.00533	CcSEcCtD
Papaverine—Rash—Nateglinide—type 2 diabetes mellitus	0.00219	0.00531	CcSEcCtD
Papaverine—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00219	0.00531	CcSEcCtD
Papaverine—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.00216	0.00525	CcSEcCtD
Papaverine—Nausea—Acarbose—type 2 diabetes mellitus	0.00214	0.00519	CcSEcCtD
Papaverine—Constipation—Glipizide—type 2 diabetes mellitus	0.00213	0.00516	CcSEcCtD
Papaverine—Nausea—Nateglinide—type 2 diabetes mellitus	0.00206	0.00501	CcSEcCtD
Papaverine—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00206	0.00499	CcSEcCtD
Papaverine—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.00205	0.00497	CcSEcCtD
Papaverine—Hepatitis—Metformin—type 2 diabetes mellitus	0.00202	0.00491	CcSEcCtD
Papaverine—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.00202	0.0049	CcSEcCtD
Papaverine—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.00201	0.00488	CcSEcCtD
Papaverine—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.002	0.00484	CcSEcCtD
Papaverine—Tofisopam—CYP3A4—type 2 diabetes mellitus	0.00199	0.186	CrCbGaD
Papaverine—Constipation—Sitagliptin—type 2 diabetes mellitus	0.00198	0.0048	CcSEcCtD
Papaverine—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.00196	0.00476	CcSEcCtD
Papaverine—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.00195	0.00474	CcSEcCtD
Papaverine—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00194	0.00472	CcSEcCtD
Papaverine—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.00191	0.00464	CcSEcCtD
Papaverine—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.00191	0.00464	CcSEcCtD
Papaverine—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.00191	0.00463	CcSEcCtD
Papaverine—Malaise—Gliclazide—type 2 diabetes mellitus	0.0019	0.00461	CcSEcCtD
Papaverine—Rash—Repaglinide—type 2 diabetes mellitus	0.00189	0.0046	CcSEcCtD
Papaverine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00189	0.0046	CcSEcCtD
Papaverine—Headache—Repaglinide—type 2 diabetes mellitus	0.00188	0.00457	CcSEcCtD
Papaverine—Flushing—Metformin—type 2 diabetes mellitus	0.00188	0.00456	CcSEcCtD
Papaverine—Trimethoprim—CYP3A4—type 2 diabetes mellitus	0.00185	0.173	CrCbGaD
Papaverine—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.00185	0.00448	CcSEcCtD
Papaverine—Anorexia—Glyburide—type 2 diabetes mellitus	0.00182	0.00443	CcSEcCtD
Papaverine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.00182	0.00442	CcSEcCtD
Papaverine—Hepatitis—Losartan—type 2 diabetes mellitus	0.0018	0.00436	CcSEcCtD
Papaverine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00179	0.00435	CcSEcCtD
Papaverine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.00179	0.00434	CcSEcCtD
Papaverine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00179	0.00434	CcSEcCtD
Papaverine—Nausea—Repaglinide—type 2 diabetes mellitus	0.00178	0.00433	CcSEcCtD
Papaverine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00178	0.00432	CcSEcCtD
Papaverine—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.00177	0.0043	CcSEcCtD
Papaverine—Flushing—Irbesartan—type 2 diabetes mellitus	0.00177	0.0043	CcSEcCtD
Papaverine—Discomfort—Gliclazide—type 2 diabetes mellitus	0.00177	0.0043	CcSEcCtD
Papaverine—Vertigo—Valsartan—type 2 diabetes mellitus	0.00174	0.00422	CcSEcCtD
Papaverine—Verapamil—ABCC2—type 2 diabetes mellitus	0.00173	0.162	CrCbGaD
Papaverine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.00172	0.00419	CcSEcCtD
Papaverine—Malaise—Orlistat—type 2 diabetes mellitus	0.00172	0.00418	CcSEcCtD
Papaverine—Vertigo—Orlistat—type 2 diabetes mellitus	0.00172	0.00417	CcSEcCtD
Papaverine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.0017	0.00413	CcSEcCtD
Papaverine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00169	0.0041	CcSEcCtD
Papaverine—Flushing—Losartan—type 2 diabetes mellitus	0.00167	0.00405	CcSEcCtD
Papaverine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.00166	0.00404	CcSEcCtD
Papaverine—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.00163	0.00397	CcSEcCtD
Papaverine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00163	0.00396	CcSEcCtD
Papaverine—Discomfort—Orlistat—type 2 diabetes mellitus	0.00161	0.0039	CcSEcCtD
Papaverine—Malaise—Metformin—type 2 diabetes mellitus	0.00159	0.00386	CcSEcCtD
Papaverine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00159	0.00385	CcSEcCtD
Papaverine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00158	0.00384	CcSEcCtD
Papaverine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00158	0.00383	CcSEcCtD
Papaverine—Rash—Glipizide—type 2 diabetes mellitus	0.00157	0.00381	CcSEcCtD
Papaverine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00157	0.0038	CcSEcCtD
Papaverine—Headache—Glipizide—type 2 diabetes mellitus	0.00156	0.00378	CcSEcCtD
Papaverine—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.00154	0.00374	CcSEcCtD
Papaverine—Hepatitis—Ramipril—type 2 diabetes mellitus	0.00154	0.00374	CcSEcCtD
Papaverine—Anorexia—Valsartan—type 2 diabetes mellitus	0.0015	0.00365	CcSEcCtD
Papaverine—Malaise—Irbesartan—type 2 diabetes mellitus	0.0015	0.00364	CcSEcCtD
Papaverine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.00149	0.00363	CcSEcCtD
Papaverine—Headache—Pioglitazone—type 2 diabetes mellitus	0.00149	0.00362	CcSEcCtD
Papaverine—Discomfort—Metformin—type 2 diabetes mellitus	0.00148	0.0036	CcSEcCtD
Papaverine—Nausea—Glipizide—type 2 diabetes mellitus	0.00148	0.00358	CcSEcCtD
Papaverine—Constipation—Gliclazide—type 2 diabetes mellitus	0.00147	0.00357	CcSEcCtD
Papaverine—Rash—Glimepiride—type 2 diabetes mellitus	0.00146	0.00355	CcSEcCtD
Papaverine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00146	0.00355	CcSEcCtD
Papaverine—Rash—Sitagliptin—type 2 diabetes mellitus	0.00146	0.00354	CcSEcCtD
Papaverine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00146	0.00354	CcSEcCtD
Papaverine—Headache—Glimepiride—type 2 diabetes mellitus	0.00145	0.00353	CcSEcCtD
Papaverine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.00145	0.00352	CcSEcCtD
Papaverine—Headache—Sitagliptin—type 2 diabetes mellitus	0.00145	0.00352	CcSEcCtD
Papaverine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00143	0.00348	CcSEcCtD
Papaverine—Flushing—Ramipril—type 2 diabetes mellitus	0.00143	0.00347	CcSEcCtD
Papaverine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00142	0.00344	CcSEcCtD
Papaverine—Malaise—Losartan—type 2 diabetes mellitus	0.00141	0.00342	CcSEcCtD
Papaverine—Vertigo—Losartan—type 2 diabetes mellitus	0.00141	0.00341	CcSEcCtD
Papaverine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.0014	0.00339	CcSEcCtD
Papaverine—Nausea—Glimepiride—type 2 diabetes mellitus	0.00138	0.00335	CcSEcCtD
Papaverine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00137	0.00333	CcSEcCtD
Papaverine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00137	0.00333	CcSEcCtD
Papaverine—Anorexia—Metformin—type 2 diabetes mellitus	0.00137	0.00333	CcSEcCtD
Papaverine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00136	0.00329	CcSEcCtD
Papaverine—Constipation—Valsartan—type 2 diabetes mellitus	0.00135	0.00328	CcSEcCtD
Papaverine—Rash—Bromocriptine—type 2 diabetes mellitus	0.00132	0.0032	CcSEcCtD
Papaverine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00132	0.0032	CcSEcCtD
Papaverine—Discomfort—Losartan—type 2 diabetes mellitus	0.00132	0.00319	CcSEcCtD
Papaverine—Headache—Bromocriptine—type 2 diabetes mellitus	0.00131	0.00318	CcSEcCtD
Papaverine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00131	0.00318	CcSEcCtD
Papaverine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.00129	0.00314	CcSEcCtD
Papaverine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00129	0.00312	CcSEcCtD
Papaverine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00125	0.00303	CcSEcCtD
Papaverine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.00124	0.00302	CcSEcCtD
Papaverine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00124	0.00302	CcSEcCtD
Papaverine—Constipation—Metformin—type 2 diabetes mellitus	0.00123	0.00298	CcSEcCtD
Papaverine—Anorexia—Losartan—type 2 diabetes mellitus	0.00122	0.00295	CcSEcCtD
Papaverine—Malaise—Ramipril—type 2 diabetes mellitus	0.00121	0.00294	CcSEcCtD
Papaverine—Rash—Glyburide—type 2 diabetes mellitus	0.00121	0.00293	CcSEcCtD
Papaverine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00121	0.00293	CcSEcCtD
Papaverine—Vertigo—Ramipril—type 2 diabetes mellitus	0.00121	0.00293	CcSEcCtD
Papaverine—Headache—Glyburide—type 2 diabetes mellitus	0.0012	0.00291	CcSEcCtD
Papaverine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00118	0.00288	CcSEcCtD
Papaverine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.00118	0.00286	CcSEcCtD
Papaverine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00118	0.00285	CcSEcCtD
Papaverine—Constipation—Irbesartan—type 2 diabetes mellitus	0.00116	0.00282	CcSEcCtD
Papaverine—Verapamil—CYP1A2—type 2 diabetes mellitus	0.00116	0.108	CrCbGaD
Papaverine—Nausea—Glyburide—type 2 diabetes mellitus	0.00114	0.00276	CcSEcCtD
Papaverine—Discomfort—Ramipril—type 2 diabetes mellitus	0.00113	0.00274	CcSEcCtD
Papaverine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.00112	0.00271	CcSEcCtD
Papaverine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.00111	0.00269	CcSEcCtD
Papaverine—Constipation—Losartan—type 2 diabetes mellitus	0.00109	0.00265	CcSEcCtD
Papaverine—Rash—Gliclazide—type 2 diabetes mellitus	0.00108	0.00263	CcSEcCtD
Papaverine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00108	0.00263	CcSEcCtD
Papaverine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00108	0.00262	CcSEcCtD
Papaverine—Headache—Gliclazide—type 2 diabetes mellitus	0.00108	0.00261	CcSEcCtD
Papaverine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00107	0.00259	CcSEcCtD
Papaverine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00105	0.00255	CcSEcCtD
Papaverine—Anorexia—Ramipril—type 2 diabetes mellitus	0.00104	0.00253	CcSEcCtD
Papaverine—Nausea—Gliclazide—type 2 diabetes mellitus	0.00102	0.00248	CcSEcCtD
Papaverine—Rash—Valsartan—type 2 diabetes mellitus	0.000995	0.00242	CcSEcCtD
Papaverine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000994	0.00241	CcSEcCtD
Papaverine—Headache—Valsartan—type 2 diabetes mellitus	0.000989	0.0024	CcSEcCtD
Papaverine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000984	0.00239	CcSEcCtD
Papaverine—Rash—Orlistat—type 2 diabetes mellitus	0.000983	0.00239	CcSEcCtD
Papaverine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000983	0.00239	CcSEcCtD
Papaverine—Headache—Orlistat—type 2 diabetes mellitus	0.000977	0.00237	CcSEcCtD
Papaverine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000952	0.00231	CcSEcCtD
Papaverine—Nausea—Valsartan—type 2 diabetes mellitus	0.000938	0.00228	CcSEcCtD
Papaverine—Constipation—Ramipril—type 2 diabetes mellitus	0.000936	0.00227	CcSEcCtD
Papaverine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000928	0.00225	CcSEcCtD
Papaverine—Nausea—Orlistat—type 2 diabetes mellitus	0.000926	0.00225	CcSEcCtD
Papaverine—Rash—Metformin—type 2 diabetes mellitus	0.000906	0.0022	CcSEcCtD
Papaverine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000906	0.0022	CcSEcCtD
Papaverine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000902	0.00219	CcSEcCtD
Papaverine—Headache—Metformin—type 2 diabetes mellitus	0.000901	0.00219	CcSEcCtD
Papaverine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000873	0.00212	CcSEcCtD
Papaverine—Rash—Irbesartan—type 2 diabetes mellitus	0.000855	0.00208	CcSEcCtD
Papaverine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000855	0.00207	CcSEcCtD
Papaverine—Nausea—Metformin—type 2 diabetes mellitus	0.000854	0.00207	CcSEcCtD
Papaverine—Headache—Irbesartan—type 2 diabetes mellitus	0.00085	0.00206	CcSEcCtD
Papaverine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000806	0.00196	CcSEcCtD
Papaverine—Rash—Losartan—type 2 diabetes mellitus	0.000805	0.00195	CcSEcCtD
Papaverine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000804	0.00195	CcSEcCtD
Papaverine—Headache—Losartan—type 2 diabetes mellitus	0.0008	0.00194	CcSEcCtD
Papaverine—Verapamil—CYP3A4—type 2 diabetes mellitus	0.000766	0.0715	CrCbGaD
Papaverine—Nausea—Losartan—type 2 diabetes mellitus	0.000758	0.00184	CcSEcCtD
Papaverine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000749	0.00182	CcSEcCtD
Papaverine—Rash—Ramipril—type 2 diabetes mellitus	0.00069	0.00168	CcSEcCtD
Papaverine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00069	0.00167	CcSEcCtD
Papaverine—Headache—Ramipril—type 2 diabetes mellitus	0.000686	0.00166	CcSEcCtD
Papaverine—Nausea—Ramipril—type 2 diabetes mellitus	0.00065	0.00158	CcSEcCtD
Papaverine—PDE3A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000116	0.000303	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000116	0.000302	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000115	0.000301	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000115	0.0003	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000115	0.0003	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000115	0.000299	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000115	0.000299	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000115	0.000299	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000114	0.000297	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000113	0.000295	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000113	0.000294	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000112	0.000293	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000112	0.000293	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—C3—type 2 diabetes mellitus	0.000112	0.000293	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000112	0.000292	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000112	0.000291	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000111	0.00029	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000111	0.00029	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000111	0.00029	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000111	0.000289	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—SRC—type 2 diabetes mellitus	0.000111	0.000288	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000111	0.000288	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000109	0.000284	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000108	0.000282	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000108	0.000282	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000108	0.000282	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000108	0.000281	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—VEGFA—type 2 diabetes mellitus	0.000108	0.000281	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000107	0.000279	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000107	0.000278	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000107	0.000278	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000107	0.000278	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000106	0.000277	CbGpPWpGaD
Papaverine—PDE10A—Hemostasis—AKT1—type 2 diabetes mellitus	0.000106	0.000277	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000106	0.000276	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000105	0.000274	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000105	0.000273	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000105	0.000273	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000105	0.000273	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000105	0.000273	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000105	0.000272	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000105	0.000272	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000104	0.000271	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000103	0.000269	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000103	0.000269	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000103	0.000268	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000103	0.000268	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000103	0.000268	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000103	0.000268	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000103	0.000268	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000102	0.000267	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000102	0.000267	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000101	0.000264	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000101	0.000264	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000101	0.000264	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000101	0.000263	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—SRC—type 2 diabetes mellitus	0.000101	0.000263	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.0001	0.000261	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—CALM1—type 2 diabetes mellitus	9.96e-05	0.000259	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CYBA—type 2 diabetes mellitus	9.96e-05	0.000259	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—TGFB1—type 2 diabetes mellitus	9.89e-05	0.000258	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.86e-05	0.000257	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	9.84e-05	0.000256	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—VEGFA—type 2 diabetes mellitus	9.81e-05	0.000256	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	9.79e-05	0.000255	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PLAT—type 2 diabetes mellitus	9.75e-05	0.000254	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—GHRL—type 2 diabetes mellitus	9.75e-05	0.000254	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—CCL2—type 2 diabetes mellitus	9.63e-05	0.000251	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CALCA—type 2 diabetes mellitus	9.63e-05	0.000251	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	9.53e-05	0.000248	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	9.49e-05	0.000247	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—AKT2—type 2 diabetes mellitus	9.46e-05	0.000246	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	9.45e-05	0.000246	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	9.37e-05	0.000244	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—GCG—type 2 diabetes mellitus	9.37e-05	0.000244	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	9.36e-05	0.000244	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—IRS1—type 2 diabetes mellitus	9.33e-05	0.000243	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	9.22e-05	0.00024	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	9.19e-05	0.000239	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	9.07e-05	0.000236	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	9.02e-05	0.000235	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—TGFB1—type 2 diabetes mellitus	9.01e-05	0.000235	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	8.95e-05	0.000233	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—INS—type 2 diabetes mellitus	8.93e-05	0.000233	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—GCG—type 2 diabetes mellitus	8.91e-05	0.000232	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PTPN1—type 2 diabetes mellitus	8.91e-05	0.000232	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—GNB3—type 2 diabetes mellitus	8.87e-05	0.000231	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.79e-05	0.000229	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	8.77e-05	0.000229	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	8.77e-05	0.000228	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—AVP—type 2 diabetes mellitus	8.75e-05	0.000228	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MMP3—type 2 diabetes mellitus	8.75e-05	0.000228	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	8.74e-05	0.000228	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IGF2—type 2 diabetes mellitus	8.71e-05	0.000227	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	8.67e-05	0.000226	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.64e-05	0.000225	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.64e-05	0.000225	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	8.62e-05	0.000224	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	8.61e-05	0.000224	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.6e-05	0.000224	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	8.58e-05	0.000224	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—APOB—type 2 diabetes mellitus	8.46e-05	0.00022	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.42e-05	0.000219	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—CCL2—type 2 diabetes mellitus	8.34e-05	0.000217	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—EDN1—type 2 diabetes mellitus	8.32e-05	0.000217	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.21e-05	0.000214	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—AKT2—type 2 diabetes mellitus	8.2e-05	0.000214	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	8.19e-05	0.000213	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	8.15e-05	0.000212	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—GNB3—type 2 diabetes mellitus	8.08e-05	0.00021	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—LPL—type 2 diabetes mellitus	8.07e-05	0.00021	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—AVP—type 2 diabetes mellitus	7.97e-05	0.000208	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.97e-05	0.000208	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.93e-05	0.000207	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.9e-05	0.000206	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.9e-05	0.000206	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.84e-05	0.000204	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.84e-05	0.000204	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.82e-05	0.000204	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.75e-05	0.000202	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—APOB—type 2 diabetes mellitus	7.7e-05	0.000201	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.68e-05	0.0002	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.67e-05	0.0002	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—AVP—type 2 diabetes mellitus	7.58e-05	0.000197	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.58e-05	0.000197	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.58e-05	0.000197	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.58e-05	0.000197	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.55e-05	0.000197	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.51e-05	0.000196	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.44e-05	0.000194	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.44e-05	0.000194	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—RELA—type 2 diabetes mellitus	7.37e-05	0.000192	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—LPL—type 2 diabetes mellitus	7.35e-05	0.000192	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—APOB—type 2 diabetes mellitus	7.33e-05	0.000191	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.3e-05	0.00019	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—C3—type 2 diabetes mellitus	7.27e-05	0.000189	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.21e-05	0.000188	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.2e-05	0.000188	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—LPL—type 2 diabetes mellitus	6.99e-05	0.000182	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.93e-05	0.000181	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.92e-05	0.00018	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—AGT—type 2 diabetes mellitus	6.91e-05	0.00018	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.9e-05	0.00018	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—AKT1—type 2 diabetes mellitus	6.87e-05	0.000179	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.85e-05	0.000178	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.79e-05	0.000177	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.78e-05	0.000177	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—APOE—type 2 diabetes mellitus	6.77e-05	0.000176	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—LEP—type 2 diabetes mellitus	6.77e-05	0.000176	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.71e-05	0.000175	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.69e-05	0.000174	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.65e-05	0.000173	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—C3—type 2 diabetes mellitus	6.62e-05	0.000173	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.61e-05	0.000172	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.56e-05	0.000171	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.44e-05	0.000168	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.38e-05	0.000166	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.31e-05	0.000165	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.3e-05	0.000164	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—C3—type 2 diabetes mellitus	6.3e-05	0.000164	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—AGT—type 2 diabetes mellitus	6.29e-05	0.000164	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.29e-05	0.000164	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—AKT1—type 2 diabetes mellitus	6.26e-05	0.000163	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.22e-05	0.000162	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.19e-05	0.000161	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—LEP—type 2 diabetes mellitus	6.16e-05	0.000161	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—APOE—type 2 diabetes mellitus	6.16e-05	0.000161	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.1e-05	0.000159	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.09e-05	0.000159	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.04e-05	0.000157	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.01e-05	0.000156	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.99e-05	0.000156	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—AGT—type 2 diabetes mellitus	5.98e-05	0.000156	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.88e-05	0.000153	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—LEP—type 2 diabetes mellitus	5.86e-05	0.000153	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—APOE—type 2 diabetes mellitus	5.86e-05	0.000153	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.81e-05	0.000151	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.8e-05	0.000151	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—SRC—type 2 diabetes mellitus	5.8e-05	0.000151	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—INS—type 2 diabetes mellitus	5.78e-05	0.000151	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.69e-05	0.000148	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.64e-05	0.000147	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.59e-05	0.000146	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.59e-05	0.000146	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.56e-05	0.000145	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.53e-05	0.000144	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.5e-05	0.000143	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.31e-05	0.000138	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—INS—type 2 diabetes mellitus	5.27e-05	0.000137	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.23e-05	0.000136	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.18e-05	0.000135	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.18e-05	0.000135	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.09e-05	0.000133	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.09e-05	0.000133	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.08e-05	0.000132	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.07e-05	0.000132	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.07e-05	0.000132	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.07e-05	0.000132	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—INS—type 2 diabetes mellitus	5.01e-05	0.00013	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.93e-05	0.000128	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.84e-05	0.000126	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.84e-05	0.000126	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.84e-05	0.000126	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.82e-05	0.000126	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—RELA—type 2 diabetes mellitus	4.77e-05	0.000124	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.62e-05	0.00012	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.62e-05	0.00012	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.6e-05	0.00012	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.39e-05	0.000114	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.39e-05	0.000114	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—RELA—type 2 diabetes mellitus	4.35e-05	0.000113	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.34e-05	0.000113	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.3e-05	0.000112	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.28e-05	0.000111	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—RELA—type 2 diabetes mellitus	4.13e-05	0.000108	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.07e-05	0.000106	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.02e-05	0.000105	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.96e-05	0.000103	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.95e-05	0.000103	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.92e-05	0.000102	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.9e-05	0.000102	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.9e-05	0.000101	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.76e-05	9.81e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—SRC—type 2 diabetes mellitus	3.75e-05	9.77e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.73e-05	9.72e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.7e-05	9.65e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.7e-05	9.65e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.67e-05	9.55e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.65e-05	9.52e-05	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.6e-05	9.38e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.59e-05	9.36e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.52e-05	9.18e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.49e-05	9.08e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.42e-05	8.9e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—SRC—type 2 diabetes mellitus	3.42e-05	8.9e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.35e-05	8.73e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.33e-05	8.67e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.29e-05	8.56e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—SRC—type 2 diabetes mellitus	3.25e-05	8.46e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.16e-05	8.24e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.05e-05	7.96e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.99e-05	7.8e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.9e-05	7.57e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.85e-05	7.42e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IL6—type 2 diabetes mellitus	2.53e-05	6.58e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.33e-05	6.07e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.3e-05	5.99e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IL6—type 2 diabetes mellitus	2.19e-05	5.7e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.12e-05	5.53e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.02e-05	5.26e-05	CbGpPWpGaD
